期刊文献+

CD83、CD1a和Ki-67在大肠癌中的表达及意义 被引量:9

Prognostic significance of CD83,CD1a and Ki-67 expression in colorectal carcinoma
下载PDF
导出
摘要 目的:探讨CD83、CD1a和Ki-67在大肠癌组织中的表达及预后意义.方法:采用免疫组织化学和流式细胞术检测60例大肠癌组织中CD83、CD1a和Ki-67的表达情况,并分析其与大肠癌临床病理特点和预后的关系.结果:免疫组织化学检测显示,低Dukes分期、预后好的癌组织中CD83和CD1a阳性率均显著高于对应组(均P<0.05),而FCM检测只显示CD1a阳性率显著高于对应组(均P<0.05);两检测均显示,高Dukes分期、预后差的癌组织中Ki-67阳性率显著高于对应组(均P<0.05).结论:CD83、CD1a和Ki-67的表达与大肠癌Dukes分期和预后相关,可以作为检测大肠癌预后的参考指标. AIM:To analyze the prognostic significance of CD83, CD1a, and Ki-67 expression in colorectal carcinoma.METHODS:The expression of CD83, CD1a, and Ki-67 in 60 cases of colorectal cancer was detected by immunohistochemistry and flow cytometry(FCM).The correlations of CD83, CD1a, and Ki-67 expression with clinicopathological parameters and prognosis in colorectal cancer were analyzed.RESULTS:Immunohistochemistry analysis showed that the positive rates of CD83 and CD1a in early-stage(Dukes' stage) colorectal cancer patients and those with a good prognosis were significantly higher than those in advanced-stage patients and those with a poor prognosis, respectively(all P 0.05).FCM analysis showed that the positive rate of CD1a was significantly higher in early-stage colorectal cancer patients and those with a good prognosis than in advanced-stage patients and those with a poor prognosis, respectively(both P 0.05).Both immunohistochemistry and FCM results showed that the positive rate of Ki-67 was significantly lower in early-stage colorectal cancer patients and those with a good prognosis than in advanced-stage patients and those with a poor prognosis, respectively(both P 0.05).CONCLUSION:CD83, CD1a, and Ki-67 expression is correlated with the Dukes' stage and prognosis of colorectal cancer and can therefore be used as a prognostic parameter for the disease.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第3期256-261,共6页 World Chinese Journal of Digestology
基金 贵州省优秀科技教育人才省长专项资金资助项目 No.(2007)79 贵州省卫生厅科学技术基金资助项目 No.D-280 遵义医学院附属医院硕士启动基金资助项目 No.(2008)33~~
关键词 大肠癌 预后 CD83 CD1A KI-67 Colorectal cancer Prognosis CD83 CD1a Ki-67
  • 相关文献

参考文献31

  • 1Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
  • 2Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
  • 3王双双,关景明,范玉晶.大肠癌发病的相关因素[J].世界华人消化杂志,2005,13(4):534-536. 被引量:32
  • 4Atreya I, Neurath MF. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Rev Anticancer Ther 2008; 8: 561-572.
  • 5Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 2003; 104: 92-97.
  • 6郜明,吴家明,陆茵.肿瘤微环境与肿瘤的恶变[J].癌变.畸变.突变,2008,20(5):412-414. 被引量:18
  • 7Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, Rimoldi D, Liénard D, Gugerli O, Ferradini L, Robert C, Avril MF, Zitvogel L, Angevin E. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 2004; 64: 2192-2198.
  • 8贺子彪,杨伟明,焦保庭,宋辉.体外联合抗原修饰的树突状细胞的抗癌效应[J].世界华人消化杂志,2008,16(1):105-108. 被引量:6
  • 9Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol 2003; 30: 23-29.
  • 10石彦,余佩武,雷晓,曾冬竹,王自强,赵永亮,唐波.树突状细胞在胃癌组织中的分布特征及与预后的关系[J].第三军医大学学报,2006,28(5):394-396. 被引量:4

二级参考文献116

共引文献73

同被引文献103

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部